Evidence map›Paper›PMID 30933074›Full record

ArticleJournal of visualized experiments : JoVE2019

Cell-free Protein Expression Using the Rapidly Growing Bacterium Vibrio natriegens.

Daniel J Wiegand, Henry H Lee, Nili Ostrov, George M Church

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Establishing a Cell-Free Transcription-Translation Platform forACS biomaterials science & engineering · 2023
    Article
  3. Ploidy inGenes · 2023
    Review
  4. Cell-free Biosynthesis of Peptidomimetics.Biotechnology and bioprocess engineering : BBE · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Effective Use of Linear DNA in Cell-Free Expression Systems.Frontiers in bioengineering and biotechnology · 2021
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel J WiegandDepartment of Genetics, Harvard Medical School; Wyss Institute for Biologically Inspired Engineering; Daniel.Wiegand@wyss.harvard.edu.
Henry H LeeDepartment of Genetics, Harvard Medical School.
Nili OstrovDepartment of Genetics, Harvard Medical School; nili_ostrov@hms.harvard.edu.
George M ChurchDepartment of Genetics, Harvard Medical School; Wyss Institute for Biologically Inspired Engineering; gchurch@genetics.med.harvard.edu.

Funding

A minimally invasive synthetic bio-driven approach for natural products discoveryU01GM110714 · NIGMS · ROCKEFELLER UNIVERSITY · PI BRADY, SEAN F · 2015 to 2019
$11.1M
NIGMS NIH HHS U01 GM110714
6 · The paper itself

Abstract

The marine bacterium Vibrio natriegens has garnered considerable attention as an emerging microbial host for biotechnology due to its fast growth rate. A general protocol is described for the preparation of V. natriegens crude cell extracts using common laboratory equipment. This high yielding protocol has been specifically optimized for user accessibility and reduced cost. Cell-free protein synthesis (CFPS) can be carried out in small scale 10 μL batch reactions in either a 96- or 384-well format and reproducibly yields concentrations of > 260 μg/mL super folder GFP (sfGFP) within 3 h. Overall, crude cell extract preparation and CFPS can be achieved in 1-2 full days by a single user. This protocol can be easily integrated into existing protein synthesis pipelines to facilitate advances in bio-production and synthetic biology applications.

Indexed as

Protein BiosynthesisBiochemistryCentrifugationFreezingRNA, MessengerSonicationVibrioRNA, Messenger

Identifiers

PMID30933074
PMCPMC6512795

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.